Results from the SWOG S1011 and LEA trials show that extended pelvic lymph node dissection during radical cystectomy for muscle-invasive bladder cancer offers no survival benefit. Novel perioperative ...
To elucidate the real-world oncological outcomes of robot-assisted radical prostatectomy (RARP) and effectiveness of extended pelvic lymph node dissection (ext-LDN) in the RARP era. Data from 8 194 ...
1 HR = Hazard Ratio, CI = Confidence Interval. n = 149; N events = 31.0. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This abstract does not include a full text component.
Retrospective data suggest that the incidence of parametrial infiltration is low in patients with early-stage low-risk cervical cancer, which raises questions regarding the need for radical ...
Results from the PHENIX-I trial support skipping pelvic lymphadenectomy in women with early cervical cancer who have a negative sentinel lymph node biopsy. Omitting pelvic lymphadenectomy in these ...
Extended dissection did not improve recurrence-free or overall survival, but it may have a bladder cancer-specific survival benefit possibly because it removes micrometastases. Extended lymph node ...
Effect of enzalutamide on anticoagulant therapy with edoxaban in patients with prostate cancer. This is an ASCO Meeting Abstract from the 2025 ASCO Genitourinary Cancers Symposium. This abstract does ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results